|
|
|
|
| Tell us what you think
|
|
|
| Home
|
|
|
Demographics and Health Effects Key findings, Recommendations, Slide kit
|
|
|
Efficacy Key findings, Recommendations, Areas for further research, Slide kit
|
|
|
Health Economics Key findings, Recommendations, Areas for further research
|
|
|
Policy Key findings, Recommendations, Areas for further research, Slide kit
|
|
|
Safety Key findings, Recommendations, Areas for further research, Slide kit
|
|
|
| Resource library
|
|
|
| Useful organisations
|
|
|
| About Us
|
|
|
|
|

Key findings
- An international public health treaty on tobacco control came into force on 27 February 2005. This is the world's first public health treaty, the World Health Organization Framework Convention on Tobacco Control (FCTC), which was unanimously adopted by WHO's 192 Member States in May 2003. Currently, 152 Parties (countries) have ratified the FCTC; ratification binds a Member State to implement the provisions of the treaty. Article 14 covers tobacco cessation and treatment strategies.
commentary and supporting evidence
- Increasing tobacco cessation is essential if we are to reduce the
morbidity and mortality caused by tobacco use within the next 30 to 50
years. For example, the World Health Organization Tobacco Free
Initiative states "Tobacco is the second major cause of death in the
world. It is currently responsible for the death of one in ten adults
worldwide (about 5 million deaths each year). If current smoking
patterns continue, it will cause some 10 million deaths each year by
2020. Half the people that smoke today - that is about 650 million
people - will eventually be killed by tobacco."
All of these are current tobacco users and, therefore, only
interventions that encourage and enable them to stop will reduce this
morbidity and mortality in the short to medium term.
commentary and supporting evidence
- To be most effective, tobacco control efforts should be truly
comprehensive, and include for example, mass media campaigns on tobacco
and health issues, tobacco product advertising bans, increased taxation
on tobacco products, bans on smoking in the workplace/public places and
systematic access to treatment. The use of misleading labeling on
tobacco products, for example, 'light' and 'mild', which may dissuade
smokers from quitting and therefore undermine treatment, should also be
banned. These policies act together to increase motivation to quit,
encourage quit attempts, reduce per capita consumption, and help
maintain abstinence. Treatment programs complement other tobacco
control policies by enhancing/creating the availability of cessation
support, thereby increasing the chances that a quit attempt will be
successful. As the number of former tobacco users increases, support
for tobacco control measures increases, with a positive impact on
national health.
commentary and supporting evidence
- A system of effective and cost effective smoking cessation
support/treatment includes a range of treatments from minimal to
intense (see Efficacy section). Tobacco dependence treatment includes
(singly or in combination) behavioral and pharmacological interventions
such as brief advice and counseling, intensive support, and
administration of pharmaceuticals, that contribute to reducing or
overcoming tobacco dependence in individuals and in the population as a
whole.
commentary and supporting evidence
- Treatment is more likely to be offered and used if integrated into
healthcare systems, including a system to identify smokers or tobacco
users.
commentary and supporting evidence
- Tobacco dependence and withdrawal syndromes are classified as substance
use disorders under the World Health Organization International
Classification of Diseases (ICD 10). The American Psychiatric
Association has come to similar conclusions in its Diagnostic and
Statistical Manual of Mental Disorders (DSM IV), although it uses the
terms 'nicotine dependence' and 'nicotine withdrawal'. The more common
general term used to describe these diseases is addiction. Official
recognition of smoking as a dependence is important in encouraging
governments to offer treatment to smokers.
commentary and supporting evidence
- Evidence is emerging in high-income countries that smoking cessation
interventions are very cost-effective in producing population health
gain, compared with other preventive and medical interventions (see
Economics section). The findings support the role of the healthcare
system in prioritizing and funding smoking cessation interventions.
commentary and supporting evidence
|